Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary
Christopher S Trethewey1,2, Harriet S Walter1,2,3, Abdullah N M Alqahtani1,2
1Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom.
Hemasphere
|March 9, 2022
Summary
No abstract available in PubMed .


